Our History

360biolabs opened its first laboratory in Melbourne at the prestigious Burnet Institute, focusing on immunology and virology.

360biolabs expanded its scope of services and laboratory footprint to include a molecular biology suite and associated capabilities.

With a focus on building out clinical capabilities, we continued to expand our service offering to include small molecule bioanalytical chemistry.

360biolabs is a qualified vendor of Australian and international CROs. Our team aims to expand our global laboratory network to allow bioanalytical solutions for clinical trials outside Australia.

Continued investment in laboratory equipment and team to meet client demand.

360biolabs became the first Australian laboratory to develop and validate microneutralization assays to support SARS-CoV-2 vaccine studies.

In our quest to provide continued support to our clients, 360biolabs joined forces with BioAgilytix and with laboratory locations in Durham, Boston, San Diego, USA, and Hamburg, Germany.

360biolabs opens a Brisbane, Australia, laboratory to offer real-time sample PBMC processing for the expanding clinical trial sector in Queensland.

360biolabs expands our Brisbane laboratory and NATA services scope to include flow cytometry and biomarker analysis and initiates a Melbourne-based purpose-built facility that will double the laboratory footprint.

360biolabs has expanded its operations by opening a new state-of-the-art facility in the Alfred precinct. This strategic move enhances our footprint and increases our value in the Australia.